Rectal cancer recurrent

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
6 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
V Various (ATC V) 1
Mechanism of action (INN-stem analysis)
Antimetabolite 2 substances
Supportive / rescue 1 substance
Topoisomerase I inhibitor 1 substance
Platinum compound 1 substance
Unknown / small molecule 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Catharina Ziekenhuis Stichting Academic
    CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN HYDROCHLORIDE TRIHYDRATE; OXALIPLATIN; TEGAFUR, GIMERACIL, OTERACIL
    2024-512526-28-00 5 countries 2020 n=364
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Catharina Ziekenhuis Stichting Academic 1 Phase III 1
New trials by year
2020
1
← All indication landscapes